A detailed history of Team Hewins, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Team Hewins, LLC holds 8,558 shares of LLY stock, worth $6.81 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares
8,558
Holding current value
$6.81 Million
% of portfolio
1.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $6.61 Million - $8.22 Million
8,558 New
8,558 $4.99 Billion
Q1 2024

May 03, 2024

SELL
$592.2 - $792.28 $91,791 - $122,803
-155 Reduced 1.81%
8,403 $6.54 Billion
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $101,361 - $119,492
193 Added 2.31%
8,558 $4.99 Billion
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $3.64 Million - $5.01 Million
8,365 New
8,365 $4.49 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Team Hewins, LLC Portfolio

Follow Team Hewins, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Team Hewins, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Team Hewins, LLC with notifications on news.